NCT01997866 Effects of Treating Sleep Apnea in Patients With Congestive Heart Failure Status WITHDRAWN Phase NA
NCT01996397 Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy Status COMPLETED Phase NA
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant Status COMPLETED Phase NA
NCT01989208 Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients Status COMPLETED Phase NA
NCT01981642 Noninvasive Diagnostics in Left Ventricular Assist Device Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT01978028 Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose Status TERMINATED Phase PHASE4
NCT01977703 Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD). Status COMPLETED Phase NA
NCT01973335 Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure Status COMPLETED Phase PHASE4
NCT01971944 The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure Status COMPLETED Phase N/A
NCT01962688 Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment Status TERMINATED Phase NA
NCT01960920 Effects of Air Pollution Exposure Reduction by Filter Mask on Heart Failure Status COMPLETED Phase NA
NCT01960153 Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage Status WITHDRAWN Phase PHASE3
NCT01956721 Impact of Heart Failure on Calcium Homeostasis and Mitochondrial Function in Human Skeletal Muscle Status TERMINATED Phase NA
NCT01956006 Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure Status COMPLETED Phase PHASE1/PHASE2
NCT01955694 Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone Status COMPLETED Phase PHASE2
NCT01951638 Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED) Status COMPLETED Phase PHASE2